Physical finds Biden ‘fit’ for the job, but report does not say he had a cognitive exam

www.foxnews.com

Kyle Morris

The White House on Friday released a copy of results from President Biden‘s first physical exam, which claims he is fit to lead the nation and highlights observations including his “stiffened” walking pattern.

Biden, who turns 79 on Saturday, was evaluated for his first physical since taking office by White House physician Kevin O’Connor. According to O’Connor’s examination, Biden “remains a healthy, vigorous, 78-year-old male, who is fit to successfully execute the duties of the Presidency.”

While O’Connor did not report any vital health concerns regarding the president, the results of his exam noted that Biden’s current medical considerations include “a-fib with normal ventricular response, hyperlipidemia, gastroesophageal reflux, seasonal allergies, spinal arthritis and mild sensory peripheral neuropathy of both feet.”

BIDEN RESUMES DUTIES AS PRESIDENT AFTER NAMING HARRIS ACTING PRESIDENT WHILE UNDER ANESTHESIA

U.S. President Joe Biden, who was given a physical this morning at Walter Reed National Military Medical Center, walks from Marine One upon his return to the White House in Washington, U.S., November 19, 2021.

U.S. President Joe Biden, who was given a physical this morning at Walter Reed National Military Medical Center, walks from Marine One upon his return to the White House in Washington, U.S., November 19, 2021. (REUTERS/Kevin Lamarque )

O’Connor, who has served as Biden’s doctor since 2009, noted two observations in Biden that have changed over recent time, including the frequent clearing of his throat and a stiffened gait. He also highlighted the discovery of “mild peripheral neuropathy” in Biden’s foot, but a cause could not be determined.

Speaking to Fox News after examining the results of the exam, Dr. Marc Siegel, a Clinical Professor of Medicine and a practicing internist at NYU Langone Medical Center, said he has some concerns about information lacking from the report that would provide a clearer understanding of the gait issue Biden faces.

“I don’t like that they ascribe his gait issues to a broken foot. First of all, why did he fall,” Siegel inquired, adding that the report also “prescribes the gait problem to spondylosis.”

(Fox news)

“That’s an incomplete characterization,” Siegel continued, stressing the importance of understanding why Biden is facing certain health issues. “What I want to know is, where’s the MRIs and where’s the EMGs?

“They did a thorough neurological exam, but they also need to do a nerve conduction EMG, and they need to do an MRI of the brain and the spinal cord to try and explain where this gait problem comes from,” Siegel said.

O’Connor’s report did not include a cognitive exam of the president, as several of his critics have said should be done. Siegel suggested that other tests to evaluate Biden’s health could “rule out” things that could potentially be associated with cognitive decline.

“If we’re looking into neurological causes for the gait change, I don’t think the way they characterize that in the physical is sufficient,” Siegel said. “I want more information. I want to know what the MRIs show, and I want to know what the nerve conduction EMG shows to rule out things that are more extensive, that by the way, can be associated with cognitive changes like mental status, like dementia.”

“This is not a fully characterized neurological assessment of somebody with a gait problem, and I want to know why,” Siegel added, noting that normal pressure hydrocephalus, a condition relating to fluid on the brain, is a “possibility” for certain medical issues. “That can be associated with cognitive loss.”

(iStock)

(iStock)

O’Connor also noted that during a “regularly scheduled screening colonoscopy” a “benign-appearing polyp was identified in the ascending colon.” That polyp was “removed without difficulty.”

The report, which stated Biden “works out at least five days per week,” noted the president currently “takes three common prescription medications and two common over-the-counter medications.”

Since before he announced his candidacy for president, and especially since taking office, Biden’s overall health and cognitive state have been a concern for many Americans. From persistent coughs and stumbles to his mangling of words and awkward mannerisms, Biden has faced questions.

https://www.foxnews.com/politics/biden-physical-forgoes-cognitive-exam-report-finds-president-to-be-healthy-vigorous

Rittenhouse could have potential defamation case against Biden over White supremacist tweet, expert says

Louis Casiano

Kyle Rittenhouse could potentially have a defamation case against President Biden over a tweet suggesting Rittenhouse was a White supremacist, a lawyer who represented former Covington Catholic High School student Nicholas Sandmann told Fox News. 

Todd McMurtry, who helped Sandmann reach a settlement with CNN over a defamation lawsuit, said Biden could be held accountable for the Sept. 30, 2020 social media post weeks before he was elected.

KYLE RITTENHOUSE FOUND NOT GUILTY ON ALL COUNTS IN KENOSHA TRIAL

placeholder

“There’s no other way to put it: the President of the United States refused to disavow white supremacists on the debate stage last night,” Biden’s tweet said. 

The remarks were accompanied by a video showing White nationalists marching in Charlottesville, Virginia, and other images. A voice-over of Fox News’ Chris Wallace is heard asking then-President Trump during a presidential debate if he was willing to condemn White supremacists and militia groups. 

At one point in the video, an image of Rittenhouse shows him holding an AR-style rifle on the night he killed two protesters and wounded a third in Kenosha, Wisconsin, during unrest after the police shooting of Jacob Blake a month earlier. 

“What you take from that tweet is that Kyle Rittenhouse was using his rifle and engaging in White supremacist misconduct so it’s actionable,” McMurtry told Fox News. “Not necessarily going to win, but it’s actionable.”

A Kenosha County jury acquitted Rittenhouse on Friday of all the charges against him, including first-degree intentional homicide and recklessly endangering safety. 

McMurtry noted Biden was not president at the time of the tweet, meaning he would not have any presidential or congressional immunity. Rittenhouse’s mother, Wendy Rittenhouse, told “Hannity” last week that Biden cast her son as a White supremacist for votes. 

“When I saw that I was shocked, I was angry. President Biden don’t know my son whatsoever, and he’s not a White supremacist,” she said. “He’s not a racist. And [Biden] did that for the votes. And I was so angry for a while at him and what he did to my son. He defamed him.”

placeholder
In this Tuesday, Aug. 25, 2020, file photo, Kyle Rittenhouse carries a weapon as he walks along Sheridan Road in Kenosha, Wis., during a night of unrest following the police shooting of Jacob Blake.  (AP/The Journal Times)

In this Tuesday, Aug. 25, 2020, file photo, Kyle Rittenhouse carries a weapon as he walks along Sheridan Road in Kenosha, Wis., during a night of unrest following the police shooting of Jacob Blake.  (AP/The Journal Times)

During an appearance on Fox News’ “America Reports,” Leo Terrell, a civil rights lawyer and Fox News contributor, said Biden had no facts to justify his remarks. 

“Let me give Joe Biden advice: Be very careful what you say because you’re subject to a possible defamation lawsuit,” Terrell said after the verdict. “This was a statement that Joe Biden is going to have to pay for and justify.”

The reactions against Rittenhouse and McMurtry’s former client have parallels: both were minors and were private figures, McMurtry said. To hold someone liable for defamation against a private figure, lawyers would only have to prove negligence on the part of whomever made the defamatory statement as opposed to actual malice, a higher burden of proof for public figures such as celebrities and elected officials, McMurtry said.

Sandmann, a Kentucky resident, and CNN settled a $250 million defamation lawsuit in January 2020 over the network’s coverage of his viral confrontation with a Native American man in Washington D.C. A video clip showed Sandmann wearing a “MAGA” hat around his classmates and smiling at Nathan Phillips, who was beating a drum and singing at the Lincoln Memorial. 

Many media outlets portrayed the incident as being racially charged before additional footage appeared to show a group of Black Hebrew Israelites had provoked the confrontation.

Kyle Rittenhouse, center, enters the courtroom with his attorneys Mark Richards, left, and Corey Chirafisi for a meeting called by Judge Bruce Schroeder at the Kenosha County Courthouse in Kenosha, Wis., on Thursday. 

Kyle Rittenhouse, center, enters the courtroom with his attorneys Mark Richards, left, and Corey Chirafisi for a meeting called by Judge Bruce Schroeder at the Kenosha County Courthouse in Kenosha, Wis., on Thursday.  (Sean Krajacic/The Kenosha News)

“I think Rittenhouse may be able to do the same thing when commentators on MSNBC say he’s a school shooter, a White supremacist, even a vigilante,” McMurtry said of a lawsuit against media outlets. “Lots of media people said he was a murderer, and I think that’s actionable because that suggests that he committed a crime, and we now know that he didn’t.”

placeholder

“When you just throw this stuff out there, you take risks,” he added. 

https://www.foxnews.com/us/rittenhouse-defamation-biden-tweet

NOT GUILTY on all five counts!

FDA asks federal judge for 55 years to complete FOIA request for Pfizer vaccine information

www.theblaze.com

Chris Pandolfo

The Food and Drug Administration is asking a federal court to allow it to take nearly 55 years to release data on Pfizer’s COVID-19 vaccine to the public.

The agency said in a court filing Monday that in order to complete a Freedom of Information Act request for data and information on the Pfizer-BioNTech vaccine, it will need to process 329,000 pages of documents and can only do so at a rate of 500 pages per month. At that rate, the information requested will not be fully released until the year 2076.

The FOIA request was submitted to the FDA in August by Public Health and Medical Professionals for Transparency, a group of more than 30 international public health professionals, medical professionals, scientists, and journalists that “exist solely to obtain and disseminate the data relied upon by the FDA to license COVID-19 vaccines.” The group includes academics and medical experts from Yale, Harvard Medical School, and UCLA; alumni from the Trump administration; and prominent health experts from around the world.

PHMPT is being represented by Siri & Glimstad, a New York-based law firm that has performed millions of dollars of legal work on behalf of groups opposed to vaccine mandates.

The medical transparency group had requested “all data and information for the Pfizer vaccine” including safety and effectiveness data; a protocol for a test or study; adverse reaction reports, product experience reports, consumer complaints, and other similar data and information; a list of all active ingredients and any inactive ingredients; an assay method or other analytical method; all correspondence and written summaries of oral discussions relating to the vaccine; all records showing Pfizer and BioNTech’s testing of a particular lot; and all records showing the testing of and action on a particular lot by the FDA.

PHMPT also made a request for expedited processing of its FOIA submission, arguing there is a “compelling need” for the FDA to speedily release Pfizer vaccine data “because a lack of transparency erodes the confidence the medical and scientific community and the public have in the conclusions reached by the FDA.”

“During a time when COVID-19 vaccine mandates are being implemented over the objection of those that have questions about the data and information supporting the safety and efficacy of the Pfizer Vaccine, and individuals with these questions are being expelled from employment, school, transportation, and the military, the public has an urgent and immediate need to have access to this data,” PHMPT said in its FOIA request.

The group filed a lawsuit in September after the FDA denied their request to expedite the release of its records. In Monday’s court filing, the plaintiff and the defendant are seeking a decision from a judge to resolve a dispute over the disclosure schedule for the requested documents.

“The FDA’s promise of transparency is, to put it mildly, a pile of illusions,” attorney Aaron Siri wrote Wednesday in a blog post about the case.

“It took the FDA precisely 108 days from when Pfizer started producing the records for licensure (on May 7, 2021) to when the FDA licensed the Pfizer vaccine (on August 23, 2021). Taking the FDA at its word, it conducted an intense, robust, thorough, and complete review and analysis of those documents in order to assure that the Pfizer vaccine was safe and effective for licensure,” he wrote.

“While it can conduct that intense review of Pfizer’s documents in 108 days, it now asks for over 20,000 days to make these documents available to the public.”

The FDA argued in the court filing that to comply with federal law it must redact certain information that is exempt from the records request filed by the plaintiff. Information about Pfizer-BioNTech’s confidential business and trade secrets and personal privacy data on patients who participated in clinical trials are examples of documents the FDA is prohibited by law from releasing.

“Reviewing and redacting records for exempt information is a time-consuming process that often requires government information specialists to review each page line-by-line,” the FDA told the court. “When a party requests a large amount of records, like Plaintiff did here, courts typically set a schedule whereby the processing and production of the non-exempt portions of records is made on a rolling basis.”

The FDA said that court precedent has determined a rate of 500 pages per month to be an efficient response to a large request like the one filed by PHMPT. The agency also said it’s FOIA response office does not have enough funding or staff to answer the request at a quicker pace and that if the plaintiff wishes to hurry the process along, the group can do so by narrowing the scope of their document request.

The plaintiff argues the FDA should complete the FOIA request no later than March 3, 2022. “This 108-day period is the same amount of time it took the FDA to review the responsive documents for the far more intricate task of licensing Pfizer’s COVID-19 vaccine,” the plaintiff told the court.

“The ability of a majority of Americans to participate in civil society, and even exercise basic liberty rights, are now contingent on receiving this product,” PHMPT’s lawyers wrote, noting that President Joe Biden’s vaccine mandates have made vaccination a condition of employment for millions of Americans.

“There are few whose livelihood, education, service, and participation in civil society are not contingent on a government requirement to receive this product. On this basis alone, basic liberty and government transparency demand that the documents and data submitted by Pfizer to license this product be made available to Plaintiff and the public forthwith, precisely as contemplated by federal regulations,” the plaintiff said.

“The entire purpose of the FOIA is to assure government transparency,” the plaintiff told the judge. “It is difficult to imagine a greater need for transparency than immediate disclosure of the documents relied upon by the FDA to license a product that is now being mandated to over 100 million Americans under penalty of losing their careers, their income, their military service status, and far worse.”

The FDA granted full approval for Pfizer-BioNTech’s COVID-19 vaccine on August 23, 2021, under the label Comirnaty.

Earlier this month, a now-former employee of Ventavia Research Group, one of the companies contracted with Pfizer to run its Phase III vaccine clinical trials, made allegations that raised questions about the data submitted before Comirnaty received FDA approval.

Brook Jackson, a former regional director for Ventavia, told the British Medical Journal that her company “falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.”

After Jackson notified Ventavia of these issues, she emailed a complaint to the FDA and was fired within hours.

According to investigative reporter Paul Thacker, the FDA did not inspect Ventavia’s trial sites even though it was alerted to the issues.

Ventavia has since said it is investigating the allegations.

In a statement to the Epoch Times, the FDA declined to comment on the Ventavia matter but said it “has full confidence in the data that were used to support the Pfizer-BioNTech COVID-19 vaccine authorization and the Comirnaty approval.”

As of Nov. 17, more than 258,642,454 doses of Pfizer’s COVID-19 vaccine have been administered in the United States.

https://www.theblaze.com/news/fda-asks-federal-judge-for-55-years-to-complete-foia-request-for-vaccine-info

Oh Dear! Pray for our country!!

Black-footed Albatross – American Bird Conservancy

abcbirds.org
Black-footed Albatross


Black-footed Albatross map, NatureServeThe Black-footed Albatross is the only one of its kind commonly seen off the North American coastline. It’s rather small as albatrosses go, but still impressive, with a six-foot wingspan. Its species name, nigripes, derives from two Latin words, niger meaning “black,” and pes meaning “foot.”

Although drift nets and longline fisheries remain constant threats, the Black-footed Albatross faces a gauntlet of newer challenges: invasive predators and introduced plants on nesting islands, ingestion of plastics, and climate change.

More than 95 percent of the world’s population of Black-footed Albatross nests in the remote Northwestern Hawaiian Islands, with the largest colonies on Midway Atoll and Laysan Island. (Laysan is also home to the recently introduced Millerbird.) Although these islands are protected, they are vulnerable to the effects of sea-level rise and increased storm intensity.

 


Life over the Ocean

Black-footed Albatrosses are beautifully adapted for a life at sea and can remain airborne for hours, landing only on the water to rest or feed. Their specialized tubular noses (found among many seabirds, including Hawaiian Petrel and Newell’s Shearwater) filter salt, allowing the birds to drink seawater and giving them an excellent sense of smell.

This keen sense helps the albatross locate its prey over vast expanses of ocean. Favored foods include flying fish (both eggs and adults), squid, crustaceans, and offal thrown from ships.


They forage by seizing prey at the surface, up-ending to reach underwater, or diving short distances with wings partly spread.

Sign up for ABC’s eNews to learn how you can help protect birds
Faithful Partners, Devoted Parents

Like other albatross species, including Laysan and Waved, this bird is slow to mature, not breeding for until five years or older. It also has a low reproductive rate and mates for life.

Males are the first to arrive on the breeding grounds, where they re-claim the nest site that the bird and its partner may have used for many years. The strong pair bond shared by these birds is established and maintained through elaborate displays, including bowing, mutual preening, and head-bobbing.

The Black-footed Albatrosses’ nest, rebuilt each year, is a simple scrape in the sand, usually at or above the high-tide line in an open or sparsely vegetated area. Both birds build the nest and take turns incubating their single egg. If this egg is lost—whether to a predator or some other threat—the birds will not attempt to breed again until the following year.

Black-footed Albatross, Greg Lavaty

Black-footed Albatross in flight, showing its impressive six-foot wingspan. Photo by Greg Lavaty

For about 18 to 20 days after hatching, one parent broods and guards the nestling while other forages for food, switching off every day or two. The chick is fed by regurgitation by both parents until it fledges, at four to five months old.
Advocating for Black-footed Albatross

The Black-footed Albatross is included on the Watch List in the State of North America’s Birds 2016 report, which highlights species most in need of immediate conservation action.

ABC continues to advocate for Black-footed Albatross and other seabirds impacted by commercial fisheries. We also support legislation to ratify the Agreement on the Conservation of Albatrosses and Petrels (ACAP) by the United States. And we recently launched an interactive web-based tool to help fisheries avoid accidentally catching seabirds: fisheryandseabird.info.

ABC has also collaborated with the National Fish and Wildlife Foundation, the U.S. Fish and Wildlife Service, and other partners to secure predator-free breeding habitat for seabirds on islands in Hawaii.

Donate to support ABC’s conservation mission!

Our weekly bird profiles provide an inside look at captivating species with video, birds calls, and fast facts dashboards.

https://abcbirds.org/bird/black-footed-albatross/